6 Results for "

EP function

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "EP function" in MCE Product Catalog:

Art. -Nr.: HY-156613
CAS. Nr.: 1803270-60-1
Reinheit:  97.16%
Synonyms: EP-7041
Target:  

Factor XI

Forschungsgebiete:  

Cardiovascular Disease

Frunexian (EP-7041) is a potent and selective FXIa inhibitor . Frunexian produces anticoagulant effects and rapidly restores normal coagulation function. Frunexian can be used in thrombosis research .
loading...
    loading...
Art. -Nr.: HY-173499
CAS. Nr.: 3077339-88-6
Target:  

FKBP CDK

Forschungsgebiete:  

Cancer

HLDA-212 is a non-covalent RIPTAC that targets FKBP (target protein, TP) and multiple CDK (effector protein, EP). HLDA-212 binds to FKBP and CDK to form a stable ternary complex (TP:RIPTAC:EP), and induces cell death by blocking FKBP function. HLDA-212 selectively inhibits the proliferation of CDK-expressing cells and accumulates in CDK-expressing cells in a CDK-dependent manner. HLDA-212 exhibits antiproliferative activity in 293_HFL cells (with a GI50 of 0.011 μM). HLDA-212 holds promise for the treatment of cancers with high FKBP expression .
loading...
    loading...
Art. -Nr.: HY-156613A
CAS. Nr.: 2416857-24-2
Synonyms: EP-7041 hydrochloride
Target:  

Factor XI

Forschungsgebiete:  

Cardiovascular Disease

Frunexian hydrochloride (EP-7041 hydrochloride) is a potent and selective FXIa inhibitor . Frunexian hydrochloride produces anticoagulant effects and rapidly restores normal coagulation function. Frunexian hydrochloride can be used in thrombosis research .
loading...
    loading...
Art. -Nr.: HY-187732
CAS. Nr.: 76739-51-0
Forschungsgebiete:  

Others

EP-459 is a papain inhibitor (IC50=0.4 μg/mL) with no significant inhibitory activity against serine proteases such as trypsin, plasmin, thrombin, and urokinase. The effects of EP-459 are similar to those of E-64C (HY-100227), but differ from the functions of leupeptin and its analogs. EP-459 can serve as a titration reagent for mouse cathepsin L (precursor form/MEP) activity, covalently binding to the cysteine residue at its active site. EP-459 is also a Ca 2+-dependent active site-directed inhibitor that can inactivate chicken gizzard smooth muscle calpain II, and can be acetylated to generate Ac-Ep-459, which after radiolabeling can be used to prepare [ 3H]Ac-Ep-459 for calpain active site labeling .
loading...
    loading...
Art. -Nr.: HY-187689
CAS. Nr.: 1005056-10-9
Target:  

Arrestin

Forschungsgebiete:  

Cancer

RKN5755 is a β-arrestin1 inhibitor and a selective inhibitor of activated fibroblasts. RKN5755 binds to β-arrestin1 and interferes with the cofilin signaling pathway mediated by this protein to block its function. RKN5755 not only inhibits the enhanced migratory effect of fibroblasts co-cultured with cancer cells, but also prevents the inhibitory effect of EP3 agonists on the EP2 receptor-induced elevation of tetrodotoxin-resistant sodium currents in mouse dorsal root ganglion neurons. RKN5755 is widely used in research on related diseases such as cancer metastasis and pain .
loading...
    loading...
Art. -Nr.: HY-182513
CAS. Nr.: 459842-29-6
Forschungsgebiete:  

Others Inflammation/Immunology

ONO-8539 is an orally active prostanoid EP1 receptor antagonist with competitive, insurmountable binding and slow receptor dissociation for long-duration inhibition. ONO-8539 modulates afferent nerve function related to bladder activity, inhibits detrusor overactivity-related contractions, decreases nonvoiding contractions and voiding duration, and increases uroflow rate with ATP (HY-B2176)-induced detrusor overactivity. ONO-8539 attenuates acid-induced heartburn symptoms, extends time to first heartburn sensation, and prevents primary hypersensitivity after distal esophageal acidification. ONO-8539 can be used for the research of overactive bladder and gastroesophageal reflux disease .
loading...
    loading...